• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Document › Details

Bone Therapeutics S.A.. (3/7/18). "Press Release: Bone Therapeutics Successfully Raises EUR 19.45 Million of Commitments in Convertible Bond Placement [Not for the United States, Australia, Canada, Japan, South Africa, et al.]". Gosselies.

	Organisation	Bone Therapeutics S.A. (Euronext Brussels + Paris: BOTHE)
	Group	Bone Therapeutics (Group)
	Organisation 2	NewCap. – Investor Relations & Financial Communications
	Product	ALLOB® allogeneic bone cell product
	Product 2	investment banking
	Person	Lienard, Thomas (Bone Therapeutics 201610– Interim CEO joined 201511– as CBO before Lundbeck + Lilly + McKinsey)
	Person 2	Laurent, Pierre (NewCap. 201404 CEO + Owner)

Record changed: 2018-03-22

Advertisement

More documents for Bone Therapeutics (Group)

• [1] Bone Therapeutics S.A.. (3/7/18). "Press Release: Bone Therapeutics Announces Private Placement of Convertible Bonds [Not for the United States, Australia, Canada, Japan, South Africa, et al.]". Gosselies....
• [2] Bone Therapeutics S.A.. (12/15/17). "Press Release: Bone Therapeutics Provides Update on Equity Placement [Not for the United States, Australia, Canada, Japan, South Africa, et al.]". Gosselies....
• [3] Bone Therapeutics S.A.. (12/14/17). "Press Release: Bone Therapeutics Launches Equity Placement [Not for the United States, Australia, Canada, Japan, South Africa, et al.]". Gosselies....
• [4] Bone Therapeutics S.A.. (9/22/17). "Press Release: Bone Therapeutics and Asahi Kasei Sign Exclusive License Agreement for PREOB in Japan". Gosselies....
• [5] Bone Therapeutics S.A.. (9/20/17). "Press Release: Bone Therapeutics Announces All Patients Meet Primary Endpoint in ALLOB® Phase I/IIA Delayed-union Study Interim Analysis". Gosselies....
• [6] Bone Therapeutics S.A.. (10/11/16). "Press Release: Enrico Bastianelli to Stand Down as CEO of Bone Therapeutics. Thomas Lienard to Become Interim CEO". Gosselies....
• [7] Bone Therapeutics S.A.. (10/11/16). "Press Release: Transparency Notification Received from Theodorus II SA. Article 14 of the Law of 2 May 2007 on Disclosure of Major Holdings". Gosselies....
• [8] Bone Therapeutics S.A.. (9/15/16). "Press Release: Bone Therapeutics Receives Positive Ruling on Belgian Patent Income Deduction". Gosselies....
• [9] Bone Therapeutics S.A.. (8/30/16). "Press Release: Bone Therapeutics Announces H1 Results for 2016". Gosselies....
• [10] Bone Therapeutics S.A.. (5/19/16). "Press Release: Bone Therapeutics to Enhance Value of Its Severe Osteoporosis Program by Transitioning to Allogeneic Development". Gosselies....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Contact  |  The use of this website requires to accept the disclaimer!   |  A project of [iito] Business Intelligence © 2002-2018. Made in Germany.